Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000215

EVP, Chief Business Officer sold 32,800 shares at an average $59.34 ($1,946,220)

  • EVP, Chief Business Officer acquired 32,800 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Baroldi Joseph · EVP, Chief Business Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-03 Exercise or conversion : show line 1 in the form 10b5-1 +2,800 $31.80 $89,040 34,726 D
2025-09-03 Sale : show line 2 in the form 10b5-1 −2,800 $62.01 $173,628 31,926 D
2025-09-03 Exercise or conversion : show line 3 in the form 10b5-1 +15,000 $31.80 $477,000 46,926 D
2025-09-03 Sale : show line 4 in the form 10b5-1 −30,000 $59.09 $1,772,592 16,926 D
2025-09-03 Exercise or conversion : show line 5 in the form 10b5-1 +15,000 $31.80 $477,000 31,926 D
Open-market sales · 32,800 sh · avg $59.34 · $1,946,220

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-09-03 Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −2,800 83,900 D
2025-09-03 Exercise or conversion : show line 7 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −15,000 68,900 D
2025-09-03 Exercise or conversion : show line 8 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −15,000 53,900 D
Loading xslF345X05/edgardoc.xml…